Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Leisure Acquisition Corp Unit (LACQU)

Leisure Acquisition Corp Unit (LACQU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade LACQU with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.7500 unch
on 06/21/21
16.0000 -20.31%
on 06/10/21
+0.0500 (+0.39%)
since 05/12/21
3-Month
11.4100 +11.74%
on 04/19/21
16.0000 -20.31%
on 06/10/21
-1.8000 (-12.37%)
since 03/10/21
52-Week
9.0300 +41.20%
on 07/10/20
22.0100 -42.07%
on 02/03/21
+0.0300 (+0.24%)
since 06/19/20

Most Recent Stories

More News
Ensysce Biosciences’ Covistat Subsidiary “At Home Coronavirus Pill” Commencing to Phase 2 clinical development

Covistat to present pre-clinical data at American Thoracic Society annual meeting, May 14-19, 2021

LACQ : 14.4900 (unch)
LACQU : 12.7500 (-20.31%)
LACQW : 1.0500 (unch)
Ensysce Biosciences Receives Investigational New Drug Allowance for its Unique PF614-MPAR™ Opioid with Overdose Protection

NEW YORK and SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce”) and Leisure Acquisition Corp. (“LACQ”) (NASDAQ: LACQ, LACQU, LACQW) , a special purpose...

LACQ : 14.4900 (unch)
LACQU : 12.7500 (-20.31%)
LACQW : 1.0500 (unch)
Recro Expands Development and Manufacturing Relationship With Ensysce Biosciences

Additional Contract Broadens and Further Strengthens Customer Product Portfolio

LACQ : 14.4900 (unch)
LACQU : 12.7500 (-20.31%)
LACQW : 1.0500 (unch)
REPH : 2.09 (-0.48%)

Key Turning Points

3rd Resistance Point 14.4167
2nd Resistance Point 14.0833
1st Resistance Point 13.4167
Last Price 12.7500
1st Support Level 12.4167
2nd Support Level 12.0833
3rd Support Level 11.4167

See More

52-Week High 22.0100
Fibonacci 61.8% 17.0516
Fibonacci 50% 15.5200
Fibonacci 38.2% 13.9884
Last Price 12.7500
52-Week Low 9.0300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar